Tokyo, Japan

Takahisa Murata

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takahisa Murata: Innovator in Therapeutic Agents for Inflammatory and Allergic Diseases

Introduction

Takahisa Murata is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medical science, particularly in the development of therapeutic agents for inflammatory and allergic diseases. His innovative work aims to provide effective solutions for conditions that affect millions of people worldwide.

Latest Patents

Takahisa Murata holds a patent for a therapeutic, preventive, or improvement agent for inflammatory disease and allergic disease. The objective of this invention is to offer a novel agent for treating, preventing, or improving these conditions. The active ingredient in this agent is (±) 5,6-dihydroxy-8Z,11Z,14Z,17Z-eicosatetraenoic acid (5,6-DiHETE). This invention addresses inflammatory diseases that may arise from increased calcium concentration in vascular endothelial cells and targets various tissues and organs, including digestive, circulatory, respiratory, urinary, genital, brain, skin, eyes, and fat.

Career Highlights

Takahisa Murata is affiliated with the University of Tokyo, where he continues to engage in groundbreaking research. His work has garnered attention for its potential impact on treating inflammatory and allergic diseases, showcasing his dedication to advancing medical science.

Collaborations

Takahisa Murata collaborates with esteemed colleagues, including Tatsuro Nakamura and Taiki Hamabata. These partnerships enhance the research efforts and contribute to the development of innovative therapeutic solutions.

Conclusion

Takahisa Murata's contributions to the field of therapeutic agents for inflammatory and allergic diseases highlight his role as a leading inventor. His innovative patent demonstrates a commitment to improving health outcomes for individuals affected by these conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…